Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma. [electronic resource]
Producer: 20170428ISSN:- 1422-0067
- Angiogenesis Inhibitors -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Renal Cell -- drug therapy
- Disease Management
- Drug Resistance, Neoplasm
- Humans
- Indoles -- administration & dosage
- Molecular Targeted Therapy
- Neoplasm Metastasis
- Neoplasm Staging
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Pyrroles -- administration & dosage
- Sorafenib
- Sunitinib
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.